T-cell-receptor dose and the time of treatment during murine retrovirus infection for maintenance of immune function

Immunology

Volumn 87, Issue 2, 1996, Pages 198-204

  Liang, B ^a   Ardestani, S ^a   Marchalonis, J J ^b   Watson, R R ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE SYSTEM; IMMUNIZATION; MITOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SPLEEN CELL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0030065132     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.449551.x     Document Type: Article

References (36)

1. WATSON R.R. (1989) Minireview of murine models for acquired immune deficiency syndrome. Life Sci 44, iii.
2. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 14, 107.
3. BRADLEY W.G., OGATA N., GOOD R.A. & DAY N.K. (1993) Alteration of in vivo cytokine gene expression in mice infected with a molecular clone the defective MAIDS virus. J AIDS 7, 1.
4. SHER A., GAZZINELLI R.T., OSWALD I.P. et al. (1992) Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127, 183.
5. WANG Y., HUANG D.S., GIGGER P.T. & WATSON R.R. (1993) The kinetics of imbalanced cytokine production by T cells and macrophages during the murine AIDS. Adv Biosci 86, 335.
6. GAZZINELLI R.T., MAKINO M., CHATTOPADHYAY S.K. et al. (1992) Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 148, 182.
7. KANAGAWA O., VAUPEL B.A., GAYAMA S., KOEHLER G. & KOPF M. (1993) Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 262, 240.
8. DEHGHANPISHEH K., HUANG D.S. Schuter S.F. Watson R.R. & MARCHALONIS J.J. (1995) Production of IgG autoantibodies to T-cell receptors in mice infected with the retrovirus LP-BM5. Int Immunol 7, 31.
9. VICTOR-KOBRIN C., BONILLA F.A., BARAK A. & BONA C. (1989) Structural correlates of a regulatory idiotype. Immunol Rev 110, 151.
10. MARCHALONIS J.J., KAYMAZ H., DEDEOGLU F., SCHLUTER S.F., YOCUM D.E. & EDMUNDSON A.B. (1992) Human autoantibodies reactive with synthetic autoantigens from T-cell receptor β chain. Proc Natl Acad Sci USA 89, 3325.
11. WATSON R.R., DEHGHANPISHEH K., HUANG D.S. et al. (1995) T cell receptor Vβ peptide administration moderates immune dysfunction and cytokine dysregulation induced by murine retrovirus infection. J Immunol 155, 2282.
12. FAUCI A.S. (1993) Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011.
13. + T cells in murine acquired immunodeficiency syndrome. J Immunol 151, 1712.
14. SOUDEYNS H., REBAI N., PANTALEO G.P. et al. (1993) The T cell receptor V beta repertoire in HIV-1 infection and disease. Semin Immunol 5, 175.
15. IMBERTI L., SOTTINI A., BETTINARDI A., PUOTI M. & PRIMI D. (1991) Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 254, 860.
16. MARCHALONIS J.J., SCHLUTER S.F., WANG, E. et al. (1994) Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection and autoimmunity. Proc Soc Expt Biol 207, 129.
17. TOYONAGA B. & MAK T.W. (1987) Genes of the T-cell antigen receptor in normal and malignant T-cells. Annu Rev Immunol 5, 585.
18. KAYMAZ H., DEDEOGLU F., SCHLUTER S.F., EDMUNDSON A.B. & MARCHALONIS J.J. (1993) Reactions of anti-immunoglobulin sera with synthetic T-cell receptor peptides: implications for the three-dimensional structure and function of the TCR β chain. Int Immunol 5, 941.
19. FENG D.F. & DOOLITTLE R.F. (1987) Progressive sequence alignment as a prerequisite to correct phylogenetic trees. J Mol Evol 25, 351.
20. WANG Y., HUANG D.S., GIGER P.T. & WATSON R.R. (1994) Influence of chronic dietary ethanol on cytokine production by murine splenocytes and thymocytes. Alcohol Clin Exp Res 18, 34.
21. 51Cr-labelled targets for natural killer cytotoxicity assay. J Immunol Methods 122, 15.
22. VANDENBARK A.A., HASHIM G. & OFFNER H. (1989) Immunization with a synthetic T cell receptor V region peptide protects against EAE. Nature 341, 541.
23. HOWELL M.D., WINTERS S.T., OLEE T., POWELL H.C., CARLO D.J. & BROSTOFF S.W. (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668.
24. OFFNER H., HASHIM G.A. & VANDENBARK A.A. (1991) T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251, 430.
25. BURNS F.R., XIAOBIN L., LI X.B. & SHEN N. (1989) Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα- and Vβ-chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169, 27.
26. STEVENS D.B., KARPUS W.J., GOULD K.E. & SWANBORG R.H. (1992) Studies of Vβ8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis. J Neuroimmunol 37, 123.
27. WHITHAM R.H., KOTZIN B.L., BUENAFE A.C. et al. (1993) Treatment of relapsing EAE with T cell receptor peptides. J Neurosci Res 35, 115.
28. HASHIM G.A., VANDENBARK A.A., GALANG A.B. et al. (1990) Antibodies specific for a Vβ8 T cell receptor peptide suppress experimental autoimmune encephalomyelitis. J Immunol 144, 4621.
29. LIANG B., ARDESTANI S., CHOW H., ESKELSON C. & WATSON R.R. (1996) Prevention of vitamin E deficiency during murine retrovirus infection by maintenance of immune function. J Nutr (in press).
30. CLERICI M., HAKIM F.T., VENZON D.J. et al. (1993) Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 91, 759.
31. BALKWILL F.R. & BURKE F. (1989) The cytokine network. Immunol Today 10, 229.
32. BOUE F., WALLON C., GOUJARD C., BARRE-SINOUSSI F., GALANAUD P. & DELFRAISSY J.F. (1992) HIV induced IL-6 production by human B lymphocytes: Role of IL-4. J Immunol 148, 3761.
33. VAN SNICK J. (1990) Interleukin-6: an overview. Annu Rev Immunol 8, 253.
34. ODELEYE O.E., ESKELSON C.D. & WATSON R.R. (1992) Changes in hepatic lipid composition after infection by LP-BMS murine leukemia virus causing murine AIDS. Life Sci 51, 129.
35. MELLORS J.W., GRIFFITH B.P. et al. (1991) Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 163, 78.
36. POLI G., BRESSLER P., KINTER A. et al. (1990) Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional post-transcriptional mechanisms. J Exp Med 172, 151.